High Prevalence Of Genetic Diseases In Infants Fuels The Growth Of Prenatal Testing And Newborn Screening Market Emerges as a Core Driver of the Prenatal Testing & Newborn Screening Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Prenatal Testing & Newborn Screening Market Through 2025?
The market size for prenatal testing & newborn screening has seen a rapid expansion in recent times. Its growth is projected to rise from $6.24 billion in 2024 to $6.99 billion in 2025, at a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth in the historic period include developments in genetic testing, a rise in maternal age, enhanced awareness and education, and healthcare policies and regulations.

What's the Projected Size of the Global Prenatal Testing & Newborn Screening Market by 2029?
The market for prenatal testing and newborn screening is anticipated to expand rapidly in the forthcoming years, reaching $11.08 billion in 2029 with a 12.2% Compound Annual Growth Rate (CAGR). Genetic counseling, technological enhancements, point-of-care testing, telemedicine, and remote tracking are all factors contributing to this significant growth over the forecast period. Non-invasive prenatal testing (NIPT), preimplantation genetic testing (PGT), telemedicine consultations, maternal blood testing, and screening for hemoglobinopathies and sickle cell disease are projected to emerge as the top trends in the forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Top Growth Drivers in the Prenatal Testing & Newborn Screening Industry: What's Accelerating the Market?
The growth of the prenatal testing & newborn screening market has been spurred on by the widespread incidence of genetic diseases in infants. The World Health Organization has outlined genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Sickle cell anemia is a genetic condition that has a global impact, especially prevalent among those whose ancestors hail from Africa, America, Cuba, Central America, Saudi Arabia, and India. As per the research conducted by the Rady Children's Institute for Genomic Medicine, a US-based research institution, in Rady Children's Hospital in February 2023, 41% of infant deaths were tied to single-locus (Mendelian) genetic diseases. This widespread prevalence of genetic diseases in infants has intensified the demand for the prenatal testing and newborn screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

What Trends Will Shape the Prenatal Testing & Newborn Screening Market Through 2029 and Beyond?
Key players in the prenatal testing and newborn screening market are concentrating their efforts on launching innovative programs that employ rapid Whole Genome Sequencing (rWGS) technology. This technology can swiftly and precisely identify genetic disorders in newborns, which allows for the early diagnosis and intervention required to enhance health results. rWGS is a cutting-edge genomic method that swiftly sequences a person's entire genome. This method stands out from traditional genetic testing approaches as it captures all DNA in a person's genome and helps identify genetic variants linked to diseases or disorders. For example, Rady Children's Institute for Genomic Medicine, a company based in the United States, introduced BeginNGS program in June 2022. This project aims to identify and diagnose approximately 400 genetic disorders with known treatments before they show symptoms. The BeginNGS project is streamlining genomic sequencing processes and plans to extend its testing ability to cover around 1,000 disorders. The end goal is to conduct screening for 3.7 million newborns each year, transforming it into a standard practice in hospitals throughout the country.

What Are the Main Segments in the Prenatal Testing & Newborn Screening Market?
The prenatal testing & newborn screening market covered in this report is segmented -

1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers

Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening
2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

Which Top Companies are Driving Growth in the Prenatal Testing & Newborn Screening Market?
Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

Which Regions Will Dominate the Prenatal Testing & Newborn Screening Market Through 2029?
North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.